Tonix Pharmaceuticals Holding (TNXP) Return on Assets (2023 - 2025)
Historic Return on Assets for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 0.44%.
- Tonix Pharmaceuticals Holding's Return on Assets rose 12700.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 12700.0%. This contributed to the annual value of 0.86% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Return on Assets is 0.44%, which was up 12700.0% from 0.43% recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Return on Assets high stood at 0.38% for Q4 2023, and its period low was 1.72% during Q3 2024.
- In the last 3 years, Tonix Pharmaceuticals Holding's Return on Assets had a median value of 0.63% in 2024 and averaged 0.85%.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Return on Assets tumbled by -6900bps in 2024 and then skyrocketed by 12700bps in 2025.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Return on Assets stood at 0.38% in 2023, then crashed by -182bps to 1.06% in 2024, then surged by 58bps to 0.44% in 2025.
- Its last three reported values are 0.44% in Q3 2025, 0.43% for Q2 2025, and 0.74% during Q1 2025.